- Home
- UONEK vs BCAB Comparison
UONEK vs BCAB Comparison
Compare UONEK & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- BCAB
- Stock Information
- Founded
- UONEK 1980
- BCAB 2007
- Country
- UONEK United States
- BCAB United States
- Employees
- UONEK N/A
- BCAB N/A
- Industry
- UONEK Broadcasting
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- UONEK Consumer Discretionary
- BCAB Health Care
- Exchange
- UONEK Nasdaq
- BCAB Nasdaq
- Market Cap
- UONEK 29.7M
- BCAB 27.0M
- IPO Year
- UONEK N/A
- BCAB 2020
- Fundamental
- Price
- UONEK $0.71
- BCAB $0.34
- Analyst Decision
- UONEK
- BCAB Buy
- Analyst Count
- UONEK 0
- BCAB 2
- Target Price
- UONEK N/A
- BCAB $1.00
- AVG Volume (30 Days)
- UONEK 37.1K
- BCAB 631.0K
- Earning Date
- UONEK 03-27-2025
- BCAB 03-27-2025
- Dividend Yield
- UONEK N/A
- BCAB N/A
- EPS Growth
- UONEK N/A
- BCAB N/A
- EPS
- UONEK N/A
- BCAB N/A
- Revenue
- UONEK $449,674,000.00
- BCAB $11,000,000.00
- Revenue This Year
- UONEK N/A
- BCAB N/A
- Revenue Next Year
- UONEK N/A
- BCAB N/A
- P/E Ratio
- UONEK N/A
- BCAB N/A
- Revenue Growth
- UONEK N/A
- BCAB N/A
- 52 Week Low
- UONEK $0.60
- BCAB $0.24
- 52 Week High
- UONEK $2.07
- BCAB $4.02
- Technical
- Relative Strength Index (RSI)
- UONEK 48.92
- BCAB 41.83
- Support Level
- UONEK $0.65
- BCAB $0.28
- Resistance Level
- UONEK $0.75
- BCAB $0.40
- Average True Range (ATR)
- UONEK 0.04
- BCAB 0.04
- MACD
- UONEK 0.01
- BCAB 0.01
- Stochastic Oscillator
- UONEK 69.23
- BCAB 48.29
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.